Related Experiment Video
Updated: Sep 27, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Vascular calcification in dialysis patients: pathogenesis and consequences
Martina Reslerova1, Sharon M Moe
1Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Insights
Vascular calcification in end-stage renal disease (ESRD) is an active, cell-driven process similar to bone formation. Understanding this process is key to developing new treatments for ESRD patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Cell Biology
Background:
- Vascular calcification significantly contributes to cardiovascular complications in end-stage renal disease (ESRD).
- This condition leads to increased mortality and morbidity in ESRD patients.
Purpose of the Study:
- To investigate the cellular mechanisms underlying uremic vascular calcification.
- To identify factors involved in the transformation of vascular cells into osteoblast-like cells.
Main Methods:
- Histological examination of vessels from ESRD patients.
- In vitro experiments using cultured vascular smooth muscle cells (VSMCs) exposed to uremic serum.
Main Results:
- Uremic vascular calcification appears to be an active, cell-mediated process, akin to osteogenesis.
- Bone-associated proteins like osteopontin are found in calcified vessels of ESRD patients.
- Uremic serum promotes osteopontin expression in VSMCs.
Conclusions:
- Vascular smooth muscle cells transform into osteoblast-like cells, with phosphorus potentially playing a key role.
- Further research is needed to identify all factors involved in uremic vascular calcification.
- A deeper understanding of uremic vascular calcification pathophysiology is essential for effective therapeutic strategies in ESRD.
Background:
Vascular calcification is believed to have a crucial role in the excess cardiovascular mortality and morbidity in patients with end-stage renal disease (ESRD).
Methods And Results:
Recent evidence suggests that uremic vascular calcification is an active cell-mediated process resembling osteogenesis in bone, rather than passive precipitation of calcium and phosphorus in the setting of deranged mineral metabolism. To date, several bone-associated proteins (osteopontin, bone sialoprotein, alkaline phosphatase, and type I collagen) have been shown in histological sections of vessels obtained from patients with ESRD or calcific uremic arteriolopathy. In in vitro experiments, the addition of uremic serum upregulates osteopontin expression by cultured vascular smooth muscle cells (VSMCs).
Conclusion:
We are only beginning to understand the process by which VSMCs transform into osteoblast-like cells, although phosphorus may have a key role. Additional factors mediating or modulating the development of vascular calcification in patients with ESRD remain to be identified. Further understanding of the pathophysiological state of uremic vascular calcification is needed to design effective therapeutic strategies to intervene with this devastating condition in the ESRD population.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Hemodialysis III: Nursing Management

